NEW YORK (GenomeWeb News) – Cellular Dynamics has raised $20 million, the stem cell technologies firm said in a regulatory document filed on Wednesday.
In a Form D filed with the US Securities and Exchange Commission, the company, which filed to go public last month, did not say how it planned to use proceeds from the raise or disclose the investors, but said that eight investors participated in the offering. The securities offered were in the form of debt; options, warrants, or other rights to acquire another security; and security to be acquired upon exercise of option, option warrant, or other right to acquire security.
Cellular Dynamics announced in June its plans to raise a maximum aggregate of $57.3 million in its public offering. Based in Madison, Wis., it develops stem cell technologies for in vitro drug development, in vivo cellular therapeutics, and stem cell banking.
In 2011, the company raised $30 million in a Series B Preferred Stock financing round, and $40.6 million 2010 in Series B private equity funding.